ResMed highlights ‘ongoing momentum’ 

SAN DIEGO – ResMed’s revenue increased by 11% to $1.2 billion for the first quarter of 2025. 

It reported net income of $311.4 million, a 42% increase. 

Other results: 

• Gross margin improved 420 bps to 58.6%; non-GAAP gross margin improved 320 bps to 59.2% 
• Income from operations increased 34%; non-GAAP income from operations up 27% 
• Operating cash flow of $326 million 
• Diluted earnings per share of $2.11; non-GAAP diluted earnings per share of $2.20 

“Our first-quarter fiscal year 2025 results reflect ongoing momentum and strong execution across all areas of our business,” said Mick Farrell, chairman and CEO of ResMed. “We delivered 11% year-over-year revenue growth, and our focus on operational excellence resulted in another quarter of year-over-year margin expansion and a 34% increase in operating profit. As we celebrate 35 years of growth and innovation, our recently launched 2030 strategy will further enable us to transform sleep health, breathing health, and healthcare technology at home. By building on our leadership in connected digital health, we are driving better care, simplifying the health journey, and improving access to our therapies globally so even more people worldwide are empowered to live healthier, higher-quality lives using products and services they love.” 

Highlights for the quarter: 

• Held its 2024 Investor Day and unveiled its 2030 strategy to drive growth, profitability and shareholder returns. As part of Investor Day, it announced a five-year revenue and earnings growth outlook, supported by plans to accelerate product and technology innovation, operational excellence, commercial execution and financial strength. 
• ResMed operates two reporting units, historically named Sleep and Respiratory Care and SaaS. In alignment with the 2030 Strategy announced during Investor Day in September, these reporting units have been renamed to Sleep and Breathing Health (formerly Sleep and Respiratory Care) and Residential Care Software (formerly SaaS). 
• Announced the upcoming launch of ResMed’s first fabric mask, the AirTouch N30i, which will be available in the U.S. beginning next week.